Latest Cash Management News

Love Group Global Ltd (ASX:LVE) reported a record net operating cash flow of $974k for FY26, a 49% increase despite a 13% decline in customer cash receipts. The company plans to grow its matchmaking business in Asia and test expansion into the US and UK.

The Daintree Hybrid Opportunities Active ETF (ASX: DHOF) is making its final distribution and redemption payments as it completes wind-up, returning over $9.64 per unit to unitholders in total.

Neometals Ltd has yet to receive A$5 million from its key investor Omaha Value Holdings for the second tranche of its placement, prompting a temporary cash preservation strategy while the company awaits funds by 30 June 2026.

Yugo Metals has secured a $5 million oversubscribed placement to ramp up drilling across its gold, nickel-cobalt, and base metals projects in the Balkans, positioning the company for significant exploration milestones over the next 18 months.

ALS Limited reported a 25.8% jump in underlying net profit after tax to AUD 381.2 million for FY26, driven by strong commodity testing demand and margin expansion. The company raised its dividend and advanced major hub lab projects while navigating a post-year-end cyber incident.

Metcash Limited projects an underlying NPAT between $268 million and $270 million for FY26, buoyed by strong second-half momentum in Hardware & Tools and disciplined cost management driving cash flow and margin resilience.

EVZ Limited projects full year revenue between $120 million and $125 million for FY26, alongside an EBITDA forecast of $8.5 million to $9 million, reflecting improved margins and operational efficiency.

Tennant Minerals has reported a significant diamond drilling intersection at its Bluebird discovery, revealing 19.7 metres of intense copper-gold-bismuth mineralisation and potential to more than double the resource footprint. The company also advances a feasibility study for a regional processing facility backed by government grants.

Chariot Resources advances its Nigerian lithium acquisition with six licences transferred and spodumene confirmed in samples, while raising A$2.15 million and securing a A$3.5 million loan refinancing.

Adveritas Limited surged to $15.08 million ARR, up 91% year-on-year, powered by a new self-serve SME platform and AI-driven product enhancements.

Renowned boosts its US footprint with a landmark RE/MAX partnership and expands multi-year brokerage deals in Australia and New Zealand, driving 3% group revenue growth and positive cash flow in Q3 FY26.

Racura Oncology reported robust progress in Q3 FY2026, including launching a key lung cancer trial and unveiling a novel blood test for cardioprotection, supported by a solid $19.38 million cash position.